Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy.

Aimed at developing accurate, reliable and cost-saving analytical techniques for drugs screening we evaluated the potential of Fourier Transform (FT) InfraRed (IR) microspectroscopy (microFTIR) as a quantitative pre-diagnostic approach for the rapid identification of IR signatures of drugs targeting specific molecular pathways causing Chronic Myeloid Leukemia (CML). To obtain reproducible FTIR absorbance spectra at the necessary spatial resolution we optimized sample preparation and acquisition parameters on a single channel Mercury-Cadmium-Telluride (MCT) detector in the spectral interval of frequencies from 4000 to 800 cm(-1). Single K562 cells were illuminated by Synchrotron Radiation (SR) and a number of ~15 K562 cells spread in monolayer were illuminated by a conventional IR source (Globar), respectively. Combining IR spectral data with the results of complementary biochemical investigations carried out in samples by different analytical methods we identified and cross-validated IR signatures of drugs targeting the oncogenic protein BCR/ABL and its associated abnormal tyrosine kinase activity in K562 cell line. Unsupervised pattern recognition performed by Hierarchical Cluster Analysis (HCA) clustered the spectra of single K562 cells in two distinct groups roughly corresponding to living and to apoptotic cells, respectively. The corresponding IR spectral profiles were assumed to represent drug-resistant and drug-sensitive cells. Significant variations with increasing percentages of apoptotic cells were observed after the treatment of K562 cells with drugs that directly or indirectly target BCR/ABL. In conclusion, we suggest that microFTIR associated with multivariate data analysis may be useful to assess drug compounds in ex vivo cancer cell models and possibly peripheral blast cells from CML patients.

[1]  G. Déléris,et al.  Pharmacologic Application of Fourier Transform Infrared Spectroscopy: The in vivo Toxic Effect of Carrageenan , 2001 .

[2]  Max Diem,et al.  Infrared spectroscopy of cultured cells: II. Spectra of exponentially growing, serum-deprived and confluent cells , 2003 .

[3]  M. Ikekita,et al.  A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells , 2003, British journal of pharmacology.

[4]  G. Shah,et al.  Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[5]  M. Diem,et al.  A decade of vibrational micro-spectroscopy of human cells and tissue (1994-2004). , 2004, The Analyst.

[6]  M. Kiskinova,et al.  Performance of SISSI, the infrared beamline of the ELETTRA storage ring , 2007 .

[7]  Max Diem,et al.  Infrared Spectroscopy of Cells and Tissues: Shining Light onto a Novel Subject , 1999 .

[8]  B. Mizaikoff,et al.  Application of multivariate data-analysis techniques to biomedical diagnostics based on mid-infrared spectroscopy , 2008, Analytical and bioanalytical chemistry.

[9]  David L. Wetzel,et al.  Imaging Molecular Chemistry with Infrared Microscopy , 1999, Science.

[10]  J. M. Sanchez-Ruiz,et al.  A Fourier-transform infrared spectroscopic study of the phosphoserine residues in hen egg phosvitin and ovalbumin. , 1988, Biochemistry.

[11]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[12]  Paul Dumas,et al.  Chemical imaging of biological tissue with synchrotron infrared light. , 2006, Biochimica et biophysica acta.

[13]  P. Cohen.  The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. , 2001, European journal of biochemistry.

[14]  Guido Marcucci,et al.  The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. , 2005, Cancer cell.

[15]  Rainer Pepperkok,et al.  IR microspectroscopy of live cells , 2005 .

[16]  B. Druker,et al.  Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib , 2003, Pharmacological Reviews.

[17]  B. Rigas,et al.  Human colon adenocarcinoma cell lines display infrared spectroscopic features of malignant colon tissues. , 1992, Cancer research.

[18]  T. Meyer,et al.  Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. , 1996, Cancer research.

[19]  S. M. Goldstein,et al.  Distinct infrared spectroscopic patterns of human basal cell carcinoma of the skin. , 1993, Cancer research.

[20]  K. Budde,et al.  FTY720 (fingolimod) in renal transplantation , 2006, Clinical transplantation.

[21]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[22]  M. Manfait,et al.  Ultrastructural appraisal of the multidrug resistance in K562 and LR73 cell lines from Fourier transform infrared spectroscopy. , 1993, Cancer research.

[23]  C. Gahmberg,et al.  K562—A human erythroleukemic cell line , 1979, International journal of cancer.

[24]  S. Kazarian,et al.  Chemical Imaging of Live Cancer Cells in the Natural Aqueous Environment , 2009, Applied spectroscopy.

[25]  J Dwyer,et al.  Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy , 2005, Biopolymers.

[26]  W. McKinney,et al.  IR spectroscopic characteristics of cell cycle and cell death probed by synchrotron radiation based Fourier transform IR spectromicroscopy. , 2000, Biopolymers.

[27]  M. Caligiuri,et al.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. , 2007, The Journal of clinical investigation.

[28]  Kan-Zhi Liu,et al.  Biomolecular characterisation of leucocytes by infrared spectroscopy , 2007, British journal of haematology.

[29]  M. Diem,et al.  Infrared spectroscopy of human tissue. V. Infrared spectroscopic studies of myeloid leukemia (ML-1) cells at different phases of the cell cycle. , 1999, Biospectroscopy.

[30]  D. Virley.  Developing therapeutics for the treatment of multiple sclerosis , 2005, NeuroRX.

[31]  Paul Dumas,et al.  Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells. , 2003, Biopolymers.

[32]  B. Druker,et al.  Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.

[33]  Z. Wang,et al.  Monitoring all-trans-retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by Fourier-transform infrared spectroscopy , 2003, Leukemia.

[34]  B. Kholodenko.  Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[35]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[36]  E. Papavassiliou,et al.  Phosphodiester Stretching Bands in the Infrared Spectra of Human Tissues and Cultured Cells , 1991 .

[37]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[38]  Matthias Boese,et al.  Mid infrared microspectroscopic mapping and imaging: A bio‐analytical tool for spatially and chemically resolved tissue characterization and evaluationof drug permeation within tissues , 2007, Microscopy research and technique.

[39]  Shaul Mordechai,et al.  Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy. , 2009, The Analyst.

[40]  C. Sawyers,et al.  Structural Requirements for Function of the Crkl Adapter Protein in Fibroblasts and Hematopoietic Cells , 1998, Molecular and Cellular Biology.

[41]  E. Goormaghtigh,et al.  Infrared spectroscopy as a tool for discrimination between sensitive and multiresistant K562 cells. , 2002, European journal of biochemistry.